| PERIOD ENDING | 1-Aug-09 | 2-May-09 | 31-Jan-09 | 1-Nov-08 | | Total Revenue | 491,991 | 474,748 | 476,569 | 660,696 | | Cost of Revenue | 225,762 | 213,196 | 207,567 | 257,039 | | | Gross Profit | 266,229 | 261,552 | 269,002 | 403,657 | | | Operating Expenses | | Research Development | 107,578 | 109,448 | 119,828 | 133,451 | | Selling General and Administrative | 79,706 | 82,276 | 87,846 | 106,381 | | Non Recurring |
-
| 11,919 | 41,737 | 3,088 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 78,945 | 57,909 | 19,591 | 160,737 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,450 | 4,324 | 8,367 | 10,628 | | Earnings Before Interest And Taxes | 81,395 | 62,233 | 27,958 | 171,365 | | Interest Expense | 1,368 |
-
|
-
|
-
| | Income Before Tax | 80,027 | 62,233 | 27,958 | 171,365 | | Income Tax Expense | 14,567 | 10,479 | 3,373 | 27,123 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 65,460 | 51,754 | 24,585 | 144,242 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 364 | (371) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 65,460 | 51,754 | 24,949 | 143,871 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $65,460 | $51,754 | $24,949 | $143,871 |
|
2.03% Nasdaq 
Income Statement
